The U.S. Treasury Department placed sanctions on an Argentina-based online pharmacy, alleging it operates as a drug trafficking and money-laundering network, the agency said Thursday.
The designation of Goldpharma as a foreign narcotics trafficker by the Office of Foreign Assets Control is the latest move by the Trump administration to address the nation’s opioid epidemic.
Buenos Aires-based Goldpharma, which operates through a network of pharmacy websites, allegedly sells legitimate and illicit opioids, including Oxycodone, without the need for a prescription, according to the Treasury Department. It sells a vast majority of the illicit opioids to U.S. customers, the Treasury said.
Goldpharma didn’t immediately respond to requests for comment Thursday.
“The Goldpharma network illustrates the sophisticated tactics drug traffickers and money launderers use to capitalize on the internet and online pharmacy sites to sell highly addictive, illicit narcotics around the world,” Sigal Mandelker, the Treasury undersecretary for terrorism and financial intelligence, said in a statement.
Read the original article here: wsj.com
Get headlines, breaking news, and jobs announcements delivered to your inbox. Sign up for our daily newsletter.